Opens in a new tab

Cutting Batch Review Delays: A CDMO’s Tech Transfer Story

Aug 21, 2026
5 MIN
Forecast Collaboration

Sponsors and their CDMOs both invest heavily in supply-chain and procurement software. Many batch-critical decisions still rely on email, spreadsheets, and manual follow-ups — slowing coordination across external manufacturing partners.

This resource looks at why that gap exists, what it costs, and what a platform built for pharma collaboration specifically — rather than adapted from general supply-chain planning — needs to do differently.

Get the Resource
What You’ll Learn
  • Why generalist supply-chain and procurement platforms stop at the plant gate and what that costs in practice.
  • The three properties real pharma collaboration requires: shared master data, manufacturing and quality depth, and validation before automation.
  • A framework for evaluating whether your current platform actually reaches manufacturing and quality, or just plans around it.
Share

Related Resources

Presentation
28-Aug-2026
Forecast Collaboration
BioPhorum 2026: Rethinking CDMO Collaboration for Cell and Gene Therapy
The challenge frameworks and case studies we presented to supply-chain leadership at GSK, AstraZeneca, Merck, Pfizer, and Vertex on why short shelf lives and chain-of-identity requirements need a different collaboration playbook.
SLIDES • 24 PAGESView
Presentation
27-Aug-2026
Forecast Collaboration
Challenge Frameworks for Sponsor–CMO Collaboration (BioPhorum Deck)
The full deck behind our BioPhorum sessions — five recurring collaboration challenges, mapped to root cause and resolution.
SLIDES • 33 PAGESView
Presentation
26-Aug-2026
Quality Collaboration
AI in Pharma Collaboration: Foundational Processes First
Our internal framework for applying AI — starting with master data validation before automating anything built on top of it.
SLIDES • 19 PAGESView

Complete the form below to proceed!